We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
Hyloris Pharmaceuticals SA | EU:HYL | Euronext | Ordinary Share |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 11.70 | 11.90 | 13.00 | 0.00 | 16:40:00 |
RNS Number:4347N Soldier Limited 10 July 2003 Not for release, publication or distribution in, into or from the United States, Canada, Australia or Japan Offer by KPMG Corporate Finance on behalf of Soldier Limited ("Soldier") for Hamleys plc ("Hamleys") First closing date - level of acceptances and extension of Offer The board of Soldier announces that the Offer to acquire the entire issued and to be issued ordinary share capital of Hamleys not otherwise acquired or contracted to be acquired by Soldier has been extended and remains open for acceptance until 3.00 p.m. on 25 July 2003. Since the posting of the Original Offer Document, Soldier has announced that the Offer will be revised and increased. The Revised Increased Offer announced on 3 July 2003 will be kept open for at least 14 days following the date on which the Revised Increased Offer Document is posted to Hamleys Shareholders. As at 3.00 p.m. on 10 July 2003, valid acceptances of the Original Offer had been received in respect of, in aggregate, 556,031 Hamleys Shares, representing approximately 2.4 per cent. of the entire existing issued ordinary share capital of Hamleys. This total includes valid acceptances received from certain Independent Directors in respect of 53,000 Hamleys Shares, representing approximately 0.2 per cent. of the entire existing issued ordinary share capital of Hamleys. Further to the announcement of the Revised Increased Offer, A Holding S.A., a subsidiary of Baugur and a party acting in concert with Soldier, purchased 2,531,264 Hamleys Shares, representing approximately 11.0 per cent. of the entire existing issued ordinary share capital of Hamleys, at a price of 254 pence per Hamleys Share. On 7 July 2003, A Holding S.A. purchased a further 25,000 Hamleys Shares, representing approximately 0.1 per cent. of the entire existing issued ordinary share capital of Hamleys, at a price of 254 pence per Hamleys Share. Soldier has received irrevocable undertakings to accept (or to take steps within the undertaker's power to cause acceptance of) the Revised Increased Offer from certain Hamleys Shareholders in respect of, in aggregate, 2,845,175 Hamleys Shares, representing approximately 12.3 per cent. of the entire existing issued ordinary share capital of Hamleys. Of these, irrevocable undertakings in respect of 1,752,175 Hamleys Shares will cease to be binding in the event that a higher competing offer is made which, including any future dividend paid by Hamleys, is equal to or greater than 267 pence in cash per Hamleys Share. Irrevocable undertakings in respect of 1,093,000 Hamleys Shares will cease to be binding in the event that any higher competing offer is made. Soldier has also received irrevocable undertakings to accept (or to take steps within the undertaker's power to cause acceptance of) the Revised Increased Offer from each of the Independent Directors in respect of their entire beneficial holdings of Hamleys Shares comprising, in aggregate, 62,250 Hamleys Shares, representing approximately 0.3 per cent. of the entire existing issued ordinary share capital of Hamleys (acceptances in respect of 53,000 of these shares have already been received, as described above). These irrevocable undertakings will lapse only in the event of the Revised Increased Offer lapsing or being withdrawn. In addition, by virtue of the Hamleys Management Share Exchange Agreement (which was amended by a supplemental agreement dated 27 June 2003), Soldier has conditionally contracted to acquire, in aggregate, 36,585 Hamleys Shares from Hamleys Management, representing approximately 0.2 per cent. of Hamleys' entire existing issued ordinary share capital, together with a further 439,741 Hamleys Shares upon exercise of certain options held under the Hamleys plc Unapproved Executive Share Option Scheme. Accordingly, as at 3.00 p.m. on 10 July 2003, Soldier and its concert parties have acquired or conditionally contracted to acquire, or have received acceptances of, or undertakings to accept (or to take steps within the undertaker's power to cause acceptance of) the Revised Increased Offer in respect of, in aggregate, 6,003,305 Hamleys Shares currently in issue, representing approximately 26.0 per cent. of Hamleys' entire existing issued ordinary share capital. In addition, Soldier has conditionally contracted to acquire 439,741 Hamleys Shares upon exercise of certain options under the Hamleys plc Unapproved Executive Share Option Scheme. Prior to the Offer Period, Hamleys Management held an interest in 36,585 Hamleys Shares, representing approximately 0.2 per cent. of the entire existing issued ordinary share capital of Hamleys. In addition, prior to the Offer period, the Hamleys Management held options to subscribe for, in aggregate, a maximum of 515,819 Hamleys Shares under the Hamleys Share Schemes. The Revised Increased Offer Document and Revised Form of Acceptance will be dispatched to Hamleys Shareholders and (for information only) to participants in the Hamleys Share Schemes as soon as is practicable. Words and expressions defined in the Original Offer Document dated 19 June 2003 and set out in the Revised Increased Offer announcement dated 3 July 2003 shall apply for the purposes of this announcement. Enquiries: Gavin Anderson & Company Tel: 020 7554 1400 Neil Bennett Halldor Larusson Soldier Tel: 020 7479 7313 John Watkinson KPMG Corporate Finance Tel: 020 7311 1000 David McCorquodale Michael McDonagh This announcement does not constitute an offer or an invitation to purchase or subscribe for any securities. KPMG Corporate Finance, a division of KPMG LLP which is authorised in the United Kingdom by the Financial Services Authority for investment business activities, is acting exclusively for Soldier as financial adviser in relation to the Offer and is not acting for any other person in relation to such Offer. KPMG Corporate Finance will not be responsible to anyone other than Soldier for providing the protections afforded to its clients or for providing advice in relation to the contents of this announcement or any transaction or arrangement referred to herein. This information is provided by RNS The company news service from the London Stock Exchange END OUPDBLFFXDBXBBX
1 Year Hyloris Pharmaceuticals Chart |
1 Month Hyloris Pharmaceuticals Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions